RE:RE:RE:enough suits!BBall, I agree that these are interesting additions to the SAB, especially given their hospital affiliations.
The quote attributed to Dr. Cashman mentioned "broad" exerptise in neuro, but I suspect they were brought on for very specific reasons- advisement on clinical trial coordination from someone who manages a neuro-focused hospital, and advisement on collection and review of associated brain imaging and biomarker data.
I don't care if people here try to beat down the stock... I'm adding as opportunities arise. Our company has access to capital in the near term, so the SP is not terribly relevant at the moment, unless buying or selling. But I am more in the holding category for the next year, again adding when opportunities arise. Are these bashers annoying? Yes, yes they are. Though some are likely just expressing frustrations that we all share to some extent, as it is difficult to be patient when the opportunity before us (an that communicated for many years by management) is so great.
I have a high degree of confidence that this investment will make good money for me and help the world. If all goes well, it could turn into a fortune for my kids and help me interact bettter with my grandkids when my brain starts failing someday.
Best of luck to you, and thanks for being a voice in the wilderness.